Table of Contents 1 SGLT2 Inhibitor Market Overview 1.1 Product Overview and Scope of SGLT2 Inhibitor 1.2 SGLT2 Inhibitor Segment by Type 1.2.1 Global SGLT2 Inhibitor Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Dapagliflozin 1.2.3 Canagliflozin 1.2.4 Empagliflozin 1.2.5 Other 1.3 SGLT2 Inhibitor Segment by Application 1.3.1 SGLT2 Inhibitor Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.4 Global SGLT2 Inhibitor Market Size Estimates and Forecasts 1.4.1 Global SGLT2 Inhibitor Revenue 2015-2026 1.4.2 Global SGLT2 Inhibitor Sales 2015-2026 1.4.3 SGLT2 Inhibitor Market Size by Region: 2020 Versus 2026 2 Global SGLT2 Inhibitor Market Competition by Manufacturers 2.1 Global SGLT2 Inhibitor Sales Market Share by Manufacturers (2015-2020) 2.2 Global SGLT2 Inhibitor Revenue Share by Manufacturers (2015-2020) 2.3 Global SGLT2 Inhibitor Average Price by Manufacturers (2015-2020) 2.4 Manufacturers SGLT2 Inhibitor Manufacturing Sites, Area Served, Product Type 2.5 SGLT2 Inhibitor Market Competitive Situation and Trends 2.5.1 SGLT2 Inhibitor Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key SGLT2 Inhibitor Players (Opinion Leaders) 3 SGLT2 Inhibitor Retrospective Market Scenario by Region 3.1 Global SGLT2 Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global SGLT2 Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America SGLT2 Inhibitor Market Facts & Figures by Country 3.3.1 North America SGLT2 Inhibitor Sales by Country 3.3.2 North America SGLT2 Inhibitor Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe SGLT2 Inhibitor Market Facts & Figures by Country 3.4.1 Europe SGLT2 Inhibitor Sales by Country 3.4.2 Europe SGLT2 Inhibitor Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific SGLT2 Inhibitor Market Facts & Figures by Region 3.5.1 Asia Pacific SGLT2 Inhibitor Sales by Region 3.5.2 Asia Pacific SGLT2 Inhibitor Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America SGLT2 Inhibitor Market Facts & Figures by Country 3.6.1 Latin America SGLT2 Inhibitor Sales by Country 3.6.2 Latin America SGLT2 Inhibitor Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa SGLT2 Inhibitor Market Facts & Figures by Country 3.7.1 Middle East and Africa SGLT2 Inhibitor Sales by Country 3.7.2 Middle East and Africa SGLT2 Inhibitor Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global SGLT2 Inhibitor Historic Market Analysis by Type 4.1 Global SGLT2 Inhibitor Sales Market Share by Type (2015-2020) 4.2 Global SGLT2 Inhibitor Revenue Market Share by Type (2015-2020) 4.3 Global SGLT2 Inhibitor Price Market Share by Type (2015-2020) 4.4 Global SGLT2 Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global SGLT2 Inhibitor Historic Market Analysis by Application 5.1 Global SGLT2 Inhibitor Sales Market Share by Application (2015-2020) 5.2 Global SGLT2 Inhibitor Revenue Market Share by Application (2015-2020) 5.3 Global SGLT2 Inhibitor Price by Application (2015-2020) 6 Company Profiles and Key Figures in SGLT2 Inhibitor Business 6.1 Eli Lilly 6.1.1 Corporation Information 6.1.2 Eli Lilly Description, Business Overview and Total Revenue 6.1.3 Eli Lilly SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Eli Lilly Products Offered 6.1.5 Eli Lilly Recent Development 6.2 Boehringer Ingelheim 6.2.1 Boehringer Ingelheim SGLT2 Inhibitor Production Sites and Area Served 6.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue 6.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Boehringer Ingelheim Products Offered 6.2.5 Boehringer Ingelheim Recent Development 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson SGLT2 Inhibitor Production Sites and Area Served 6.3.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Johnson & Johnson Products Offered 6.3.5 Johnson & Johnson Recent Development 6.4 AstraZeneca 6.4.1 AstraZeneca SGLT2 Inhibitor Production Sites and Area Served 6.4.2 AstraZeneca Description, Business Overview and Total Revenue 6.4.3 AstraZeneca SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.4.4 AstraZeneca Products Offered 6.4.5 AstraZeneca Recent Development 6.5 Merck 6.5.1 Merck SGLT2 Inhibitor Production Sites and Area Served 6.5.2 Merck Description, Business Overview and Total Revenue 6.5.3 Merck SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Merck Products Offered 6.5.5 Merck Recent Development 6.6 Pfizer 6.6.1 Pfizer SGLT2 Inhibitor Production Sites and Area Served 6.6.2 Pfizer Description, Business Overview and Total Revenue 6.6.3 Pfizer SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Pfizer Products Offered 6.6.5 Pfizer Recent Development 7 SGLT2 Inhibitor Manufacturing Cost Analysis 7.1 SGLT2 Inhibitor Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of SGLT2 Inhibitor 7.4 SGLT2 Inhibitor Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 SGLT2 Inhibitor Distributors List 8.3 SGLT2 Inhibitor Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global SGLT2 Inhibitor Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of SGLT2 Inhibitor by Type (2021-2026) 10.1.2 Global Forecasted Revenue of SGLT2 Inhibitor by Type (2021-2026) 10.2 SGLT2 Inhibitor Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of SGLT2 Inhibitor by Application (2021-2026) 10.2.2 Global Forecasted Revenue of SGLT2 Inhibitor by Application (2021-2026) 10.3 SGLT2 Inhibitor Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of SGLT2 Inhibitor by Region (2021-2026) 10.3.2 Global Forecasted Revenue of SGLT2 Inhibitor by Region (2021-2026) 10.4 North America SGLT2 Inhibitor Estimates and Projections (2021-2026) 10.5 Europe SGLT2 Inhibitor Estimates and Projections (2021-2026) 10.6 Asia Pacific SGLT2 Inhibitor Estimates and Projections (2021-2026) 10.7 Latin America SGLT2 Inhibitor Estimates and Projections (2021-2026) 10.8 Middle East and Africa SGLT2 Inhibitor Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global SGLT2 Inhibitor Sales (Kg) Growth Rate Comparison by Type (2015-2026) Table 2. Global SGLT2 Inhibitor Sales (Kg) Comparison by Application: 2020 VS 2026 Table 3. Global SGLT2 Inhibitor Market Size by Type (Kg) (US$ Million) (2020 VS 2026) Table 4. Global Key SGLT2 Inhibitor Manufacturers Covered in This Study Table 5. Global SGLT2 Inhibitor Sales (Kg) by Manufacturers (2015-2020) Table 6. Global SGLT2 Inhibitor Sales Share by Manufacturers (2015-2020) Table 7. Global SGLT2 Inhibitor Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global SGLT2 Inhibitor Revenue Share by Manufacturers (2015-2020) Table 9. Global Market SGLT2 Inhibitor Average Price (USD/g) of Key Manufacturers (2015-2020) Table 10. Manufacturers SGLT2 Inhibitor Sales Sites and Area Served Table 11. Manufacturers SGLT2 Inhibitor Product Types Table 12. Global SGLT2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SGLT2 Inhibitor as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key SGLT2 Inhibitor Players Table 16. Global SGLT2 Inhibitor Sales (Kg) by Region (2015-2020) Table 17. Global SGLT2 Inhibitor Sales Market Share by Region (2015-2020) Table 18. Global SGLT2 Inhibitor Revenue (Million US$) by Region (2015-2020) Table 19. Global SGLT2 Inhibitor Revenue Market Share by Region (2015-2020) Table 20. North America SGLT2 Inhibitor Sales by Country (2015-2020) (Kg) Table 21. North America SGLT2 Inhibitor Sales Market Share by Country (2015-2020) Table 22. North America SGLT2 Inhibitor Revenue by Country (2015-2020) (US$ Million) Table 23. North America SGLT2 Inhibitor Revenue Market Share by Country (2015-2020) Table 24. Europe SGLT2 Inhibitor Sales by Country (2015-2020) (Kg) Table 25. Europe SGLT2 Inhibitor Sales Market Share by Country (2015-2020) Table 26. Europe SGLT2 Inhibitor Revenue by Country (2015-2020) (US$ Million) Table 27. Europe SGLT2 Inhibitor Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific SGLT2 Inhibitor Sales by Region (2015-2020) (Kg) Table 29. Asia Pacific SGLT2 Inhibitor Sales Market Share by Region (2015-2020) Table 30. Asia Pacific SGLT2 Inhibitor Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific SGLT2 Inhibitor Revenue Market Share by Region (2015-2020) Table 32. Latin America SGLT2 Inhibitor Sales by Country (2015-2020) (Kg) Table 33. Latin America SGLT2 Inhibitor Sales Market Share by Country (2015-2020) Table 34. Latin America SGLT2 Inhibitor Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America SGLT2 Inhibitor Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa SGLT2 Inhibitor Sales by Country (2015-2020) (Kg) Table 37. Middle East and Africa SGLT2 Inhibitor Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa SGLT2 Inhibitor Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Country (2015-2020) Table 40. Global SGLT2 Inhibitor Sales (Kg) by Type (2015-2020) Table 41. Global SGLT2 Inhibitor Sales Share by Type (2015-2020) Table 42. Global SGLT2 Inhibitor Revenue (Million US$) by Type (2015-2020) Table 43. Global SGLT2 Inhibitor Revenue Share by Type (2015-2020) Table 44. Global SGLT2 Inhibitor Price (USD/g) by Type (2015-2020) Table 45. Global SGLT2 Inhibitor Sales (Kg) by Application (2015-2020) Table 46. Global SGLT2 Inhibitor Sales Market Share by Application (2015-2020) Table 47. Global SGLT2 Inhibitor Sales Growth Rate by Application (2015-2020) Table 48. Eli Lilly SGLT2 Inhibitor Corporation Information Table 49. Eli Lilly Description and Business Overview Table 50. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 51. Eli Lilly Main Product Table 52. Eli Lilly Recent Development Table 53. Boehringer Ingelheim SGLT2 Inhibitor Corporation Information Table 54. Boehringer Ingelheim Corporation Information Table 55. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 56. Boehringer Ingelheim Main Product Table 57. Boehringer Ingelheim Recent Development Table 58. Johnson & Johnson SGLT2 Inhibitor Corporation Information Table 59. Johnson & Johnson Corporation Information Table 60. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 61. Johnson & Johnson Main Product Table 62. Johnson & Johnson Recent Development Table 63. AstraZeneca SGLT2 Inhibitor Corporation Information Table 64. AstraZeneca Corporation Information Table 65. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 66. AstraZeneca Main Product Table 67. AstraZeneca Recent Development Table 68. Merck SGLT2 Inhibitor Corporation Information Table 69. Merck Corporation Information Table 70. Merck SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 71. Merck Main Product Table 72. Merck Recent Development Table 73. Pfizer SGLT2 Inhibitor Corporation Information Table 74. Pfizer Corporation Information Table 75. Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 76. Pfizer Main Product Table 77. Pfizer Recent Development Table 78. Sales Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. SGLT2 Inhibitor Distributors List Table 81. SGLT2 Inhibitor Customers List Table 82. Market Key Trends Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 84. Key Challenges Table 85. Global SGLT2 Inhibitor Sales (Kg) Forecast by Type (2021-2026) Table 86. Global SGLT2 Inhibitor Sales Market Share Forecast by Type (2021-2026) Table 87. Global SGLT2 Inhibitor Revenue (Million US$) Forecast by Type (2021-2026) Table 88. Global SGLT2 Inhibitor Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 89. Global SGLT2 Inhibitor Sales (Kg) Forecast by Application (2021-2026) Table 90. Global SGLT2 Inhibitor Revenue (Million US$) Forecast by Application (2021-2026) Table 91. Global SGLT2 Inhibitor Sales (Kg) Forecast by Region (2021-2026) Table 92. Global SGLT2 Inhibitor Sales Market Share Forecast by Region (2021-2026) Table 93. Global SGLT2 Inhibitor Revenue Forecast by Region (2021-2026) (US$ Million) Table 94. Global SGLT2 Inhibitor Revenue Market Share Forecast by Region (2021-2026) Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Picture of SGLT2 Inhibitor Figure 2. Global SGLT2 Inhibitor Sales Market Share by Type: 2020 VS 2026 Figure 3. Dapagliflozin Product Picture Figure 4. Canagliflozin Product Picture Figure 5. Empagliflozin Product Picture Figure 6. Other Product Picture Figure 7. Global SGLT2 Inhibitor Consumption Market Share by Application: 2020 VS 2026 Figure 8. Hospital Pharmacies Figure 9. Retail Pharmacies Figure 10. Global SGLT2 Inhibitor Market Size 2015-2026 (US$ Million) Figure 11. Global SGLT2 Inhibitor Sales Capacity (Kg) (2015-2026) Figure 12. Global SGLT2 Inhibitor Market Size Market Share by Region: 2020 Versus 2026 Figure 13. SGLT2 Inhibitor Sales Share by Manufacturers in 2020 Figure 14. Global SGLT2 Inhibitor Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by SGLT2 Inhibitor Revenue in 2019 Figure 16. SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global SGLT2 Inhibitor Sales Market Share by Region (2015-2020) Figure 18. Global SGLT2 Inhibitor Sales Market Share by Region in 2019 Figure 19. Global SGLT2 Inhibitor Revenue Market Share by Region (2015-2020) Figure 20. Global SGLT2 Inhibitor Revenue Market Share by Region in 2019 Figure 21. North America SGLT2 Inhibitor Sales Market Share by Country in 2019 Figure 22. North America SGLT2 Inhibitor Revenue Market Share by Country in 2019 Figure 23. U.S. SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 24. U.S. SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 26. Canada SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe SGLT2 Inhibitor Sales Market Share by Country in 2019 Figure 28. Europe SGLT2 Inhibitor Revenue Market Share by Country in 2019 Figure 29. Germany SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 30. Germany SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 32. France SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 34. U.K. SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 36. Italy SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 38. Russia SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific SGLT2 Inhibitor Sales Market Share by Region in 2019 Figure 40. Asia Pacific SGLT2 Inhibitor Revenue Market Share by Region in 2019 Figure 41. China SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 42. China SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 44. Japan SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 46. South Korea SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 48. India SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 50. Australia SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 52. Taiwan SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 54. Indonesia SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 56. Thailand SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 58. Malaysia SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 60. Philippines SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 62. Vietnam SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America SGLT2 Inhibitor Sales Market Share by Country in 2019 Figure 64. Latin America SGLT2 Inhibitor Revenue Market Share by Country in 2019 Figure 65. Mexico SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 66. Mexico SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 68. Brazil SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 70. Argentina SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa SGLT2 Inhibitor Sales Market Share by Country in 2019 Figure 72. Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Country in 2019 Figure 73. Turkey SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 74. Turkey SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 76. Saudi Arabia SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E SGLT2 Inhibitor Sales Growth Rate (2015-2020) (Kg) Figure 78. U.A.E SGLT2 Inhibitor Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of SGLT2 Inhibitor by Type (2015-2020) Figure 80. Sales Market Share of SGLT2 Inhibitor by Type in 2019 Figure 81. Revenue Share of SGLT2 Inhibitor by Type (2015-2020) Figure 82. Revenue Market Share of SGLT2 Inhibitor by Type in 2019 Figure 83. Global SGLT2 Inhibitor Sales Growth by Type (2015-2020) (Kg) Figure 84. Global SGLT2 Inhibitor Sales Market Share by Application (2015-2020) Figure 85. Global SGLT2 Inhibitor Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of SGLT2 Inhibitor by Application (2015-2020) Figure 87. Global Revenue Share of SGLT2 Inhibitor by Application in 2020 Figure 88. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Price Trend of Key Raw Materials Figure 95. Manufacturing Cost Structure of SGLT2 Inhibitor Figure 96. Manufacturing Process Analysis of SGLT2 Inhibitor Figure 97. SGLT2 Inhibitor Industrial Chain Analysis Figure 98. Channels of Distribution Figure 99. Distributors Profiles Figure 100. Porter's Five Forces Analysis Figure 101. North America SGLT2 Inhibitor Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 102. North America SGLT2 Inhibitor Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Europe SGLT2 Inhibitor Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 104. Europe SGLT2 Inhibitor Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Latin America SGLT2 Inhibitor Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 106. Latin America SGLT2 Inhibitor Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa SGLT2 Inhibitor Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa SGLT2 Inhibitor Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific SGLT2 Inhibitor Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific SGLT2 Inhibitor Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

Eli Lilly Boehringer Ingelheim Johnson & Johnson AstraZeneca Merck Pfizer